====== Marco Cavaleri ======

{{ ::marco_cavaleri.jpeg?200|}}

**Marco Cavaleri** is a pharmacologist serving as the head of Biological Health Threats and Vaccines Strategy at the [[European Medicines Agency]] (EMA).((Kouassi, V. //Marco Cavaleri.// REVIVE. Retrieved March 8, 2023, from https://web.archive.org/web/20230308225834/https://revive.gardp.org/marco-cavaleri/))

He is an "expert" associated with the [[Global Antibiotic Research & Development Partnership]] (GARDP)'s REVIVE program.

===== History =====

==== COVID-19 ====

Cavaleri participated in a February 11-12, 2020 event titled "2019 novel Coronavirus Global research and innovation forum: towards a research roadmap" co-hosted by the [[World Health Organization]] [[R&D Blueprint]] and [[Global Research Collaboration for Infectious Disease Preparedness]] (GLOPID-R). He and [[Ana Laura Salvati]] presented on the topic of "Candidate therapeutics R&D".((//2019 novel Coronavirus Global research and innovation forum: towards a research roadmap AGENDA.// (2020). GLOPID-R. https://web.archive.org/web/20230208185417/https://www.glopid-r.org/wp-content/uploads/2020/02/covid-19-global-research-and-innovation-forum-2020-program.pdf))

Cavaleri is the Chair of the [[European Medicines Agency]]'s [[COVID-19]] Taskforce.

===== External links =====

  * [[https://www.linkedin.com/in/marco-cavaleri-78509619/|LinkedIn]]